Cumulative TCBI exposure tracked with higher stroke odds in CKM stages 0 to 3
Stroke risk in cardiovascular–kidney–metabolic syndrome does not appear to hinge on a single laboratory snapshot. In a cohort of 4,475 adults aged 45 years and older from CHARLS, long-term exposure to TCBI — the triglyceride–total cholesterol–body weight index — was associated with incident stroke across CKM stages 0 to 3. The signal was not limited to one measurement point; it strengthened when investigators considered cumulative exposure and two-time-point patterns over time.
A one-off metabolic reading can miss the burden carried year after year.
The design matters because CKM syndrome is built from interlocking cardiometabolic stressors, and stroke emerges from that accumulated vascular injury rather than a single abrupt event. By integrating triglycerides, total cholesterol, and body weight into one index, TCBI functions as a proxy for the metabolic pressure placed on the arterial system. Persistently higher values likely reflect a milieu that favors endothelial dysfunction, atherogenesis, insulin resistance, and eventually cerebrovascular events. In that sense, the finding is biologically plausible even before any risk model is applied.
Persistent metabolic burden carried the strongest association
The analysis used multivariable logistic regression and restricted cubic spline modeling to test both linear and nonlinear relationships. In the fully adjusted model, each 1-unit increase in cumulative TCBI was associated with 12% higher odds of incident stroke, with an odds ratio of 1.12 and a 95% confidence interval of 1.07 to 1.17. The pattern held when TCBI was examined longitudinally: participants in the high-level two-time-point pattern group had 66% higher odds of stroke than those in the low-level group, with an odds ratio of 1.66 and a 95% confidence interval of 1.32 to 2.08.
Those are not trivial separations. They suggest that sustained metabolic excess, rather than isolated dyslipidemia or weight elevation, maps onto a measurably higher stroke burden in middle-aged and older adults already moving through the CKM spectrum.
The investigators also examined shape, not just slope. The association was nonlinear, with an exploratory change point near 27.83. Below and above that threshold, the relationship did not behave as a simple straight line, which raises the possibility that the vascular consequences of rising TCBI intensify once a certain metabolic load is reached. For clinicians, that kind of inflection matters because it hints at a level where risk may accelerate rather than merely drift upward.
Two measurements told a different story than one snapshot
The use of two time points adds an important dimension. A single baseline index can misclassify people whose lipid and weight profiles fluctuate, improve, or deteriorate over time. By contrast, repeated elevation captures persistence — and persistence is often what injures vessels. Chronic exposure to higher triglycerides and cholesterol, especially when coupled with excess body weight, supports the atherosclerotic process through lipid deposition, inflammation, and progressive arterial stiffening. In the brain’s circulation, those changes can translate into plaque instability, impaired perfusion reserve, and a higher likelihood of thrombotic occlusion.
Participants were classified into CKM stages 0 to 3, so the findings sit within an already relevant clinical framework. Even before advanced CKM stages develop, cumulative metabolic burden was associated with stroke. The implication is not that TCBI replaces established stroke risk factors, but that it may capture a combined exposure pattern those factors alone do not fully summarize.
The study used K-means clustering to define longitudinal TCBI patterns, a method that captures real-world heterogeneity rather than forcing everyone into the same trajectory. Some adults remain relatively low and stable, while others carry consistently elevated values. The latter group faced the higher stroke odds in this cohort.
What the association can and cannot say about bedside care
These findings come from epidemiology, not intervention. They do not prove that lowering TCBI will reduce stroke events, and they do not establish TCBI as a clinical risk tool for individual decision-making. The authors were explicit on that point, and the distinction is important. Odds ratios from observational data identify a relationship; they do not show that changing the marker changes the outcome.
Still, the signal has practical relevance for clinicians thinking about cardiometabolic risk in midlife and later life. TCBI folds together triglycerides, total cholesterol, and body weight, all of which are modifiable to some degree through diet, activity, weight management, and medication when indicated. If repeated exposure is the issue, then longitudinal monitoring may be more informative than waiting for a single abnormal value to recur on paper. The biologic logic is straightforward: vessels respond to the burden they endure over time, not just the snapshot taken at one visit.
Sensitivity analyses preserved the direction of the association, which strengthens confidence that the pattern was not a statistical fluke. Even so, the study leaves open several clinically important questions: whether the same relationship appears in other populations, whether higher TCBI predicts stroke similarly across CKM subgroups, and whether any actionable threshold can be used in routine prevention. The cohort also comes from CHARLS, so broader external validation will matter before the metric is considered for broader clinical use.
Stroke prevention in CKM syndrome will still rest on established measures: blood pressure control, lipid management, diabetes care, kidney protection, smoking cessation, and weight reduction when appropriate. This study adds another layer to that framework by showing that cumulative metabolic exposure, expressed through TCBI, tracked with stroke occurrence in older Chinese adults. The next question is not whether the association exists, but whether repeated TCBI measurement can be translated into a prevention strategy that changes outcomes rather than simply describing risk more precisely.